167 related articles for article (PubMed ID: 33175311)
1. Efficacy of interleukin-1 blockade in Schnitzler's syndrome without detectable monoclonal gammopathy: a case-based review.
Bixio R; Rossini M; Giollo A
Clin Rheumatol; 2021 Jul; 40(7):2973-2977. PubMed ID: 33175311
[TBL] [Abstract][Full Text] [Related]
2. A case of Schnitzler's syndrome without monoclonal gammopathy successfully treated with canakinumab.
Fujita Y; Asano T; Sakai A; Norikawa N; Yamamoto T; Matsumoto H; Sato S; Temmoku J; Yashiro-Furuya M; Matsuoka N; Watanabe H; Migita K
BMC Musculoskelet Disord; 2021 Mar; 22(1):257. PubMed ID: 33685423
[TBL] [Abstract][Full Text] [Related]
3. A Case of Schnitzler's Syndrome without Monoclonal Gammopathy-Associated Chronic Urticaria Treated with Anakinra.
Ahn MJ; Yu JE; Jeong J; Sim DW; Koh YI
Yonsei Med J; 2018 Jan; 59(1):154-157. PubMed ID: 29214791
[TBL] [Abstract][Full Text] [Related]
4. An unusual presentation of immunoglobulin A gammopathy in a patient with Schnitzler's syndrome.
Kaganov E; Jhaveri D; Peters P; IJdo JW
Int J Rheum Dis; 2023 Oct; 26(10):2085-2088. PubMed ID: 37191194
[TBL] [Abstract][Full Text] [Related]
5. Case report: Schnitzler-like syndrome without monoclonal gammopathy.
Wesselmann AS; Künstner A; Fähnrich A; Rose C; Lamprecht P; Busch H; Ludwig RJ; Recke A
Front Immunol; 2023; 14():1166620. PubMed ID: 37063861
[TBL] [Abstract][Full Text] [Related]
6. [A woman with recurrent urticaria, joint pain and fever].
Gran JT; Midtvedt Ø; Haug S
Tidsskr Nor Laegeforen; 2011 Jan; 131(2):135-6. PubMed ID: 21267032
[TBL] [Abstract][Full Text] [Related]
7. Schnitzler's syndrome associated with pancreatitis: a disease of IL-1 dysregulation.
Larocca CA; McEvoy JW; Ellis CL; Junkins-Hopkins J; Kolb T; Baer AN; Garibaldi BT
Clin Rheumatol; 2012 Jan; 31(1):169-74. PubMed ID: 21710158
[TBL] [Abstract][Full Text] [Related]
8. Schnitzler's Syndrome: A Diagnostic Consideration in Evaluating the Constellation of Monoclonal Gammopathy and Chronic Urticaria.
Mamadgi J; Babar L; Bhagavatula R; Sadashiv S; Dantey K; Apostolova M
J Hematol; 2021 Jun; 10(3):143-146. PubMed ID: 34267853
[TBL] [Abstract][Full Text] [Related]
9. Schnitzler syndrome refractory to anakinra: successful treatment with canakinumab.
Salcedo-Mingoarranz AL; Dorado-Fernández M; García-Martínez S; Collado-Ramos P; Silvestre-Torner N
J Dermatolog Treat; 2023 Dec; 34(1):2242705. PubMed ID: 37551725
[TBL] [Abstract][Full Text] [Related]
10. Schnitzler's Syndrome-Diagnostic Experience, Approaches to Therapy, and Patient Management according to a Multicenter Russian Cohort.
Salugina SO; Torgashina AV; Borzova EY; Rameev VV; Gorodetsky VR; Fedorov ES; Muravyova NV
Dokl Biochem Biophys; 2024 Jun; ():. PubMed ID: 38861148
[TBL] [Abstract][Full Text] [Related]
11. Retention rate of IL-1 inhibitors in Schnitzler's syndrome.
Crisafulli F; Vitale A; Airò P; Grigis M; Gaggiano C; Dagna L; Cavalli G; Cimaz R; Viapiana O; Iannone F; Lopalco G; Bortolotti R; Abdel Jaber M; Montecucco C; Monti S; Balduzzi S; Emmi G; Mattioli I; Franceschini F; Cantarini L; Frassi M
Clin Exp Rheumatol; 2022 Nov; 40(11):2011-2017. PubMed ID: 35084307
[TBL] [Abstract][Full Text] [Related]
12. Schnitzler syndrome co-occurring with idiopathic multicentric Castleman disease that responds to anti-IL-1 therapy: A case report and clue to pathophysiology.
Soudet S; Fajgenbaum D; Delattre C; Forestier A; Hachulla E; Hatron PY; Launay D; Terriou L
Curr Res Transl Med; 2018 Sep; 66(3):83-86. PubMed ID: 30108026
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of Schnitzler's syndrome with anakinra after failure of rituximab trial.
Cascavilla N; Bisceglia M; D'Arena G
Int J Immunopathol Pharmacol; 2010; 23(2):633-6. PubMed ID: 20646359
[TBL] [Abstract][Full Text] [Related]
14. Schnitzler's syndrome: diagnosis, treatment, and follow-up.
Simon A; Asli B; Braun-Falco M; De Koning H; Fermand JP; Grattan C; Krause K; Lachmann H; Lenormand C; Martinez-Taboada V; Maurer M; Peters M; Rizzi R; Rongioletti F; Ruzicka T; Schnitzler L; Schubert B; Sibilia J; Lipsker D
Allergy; 2013; 68(5):562-8. PubMed ID: 23480774
[TBL] [Abstract][Full Text] [Related]
15. Beneficial response to anakinra and thalidomide in Schnitzler's syndrome.
de Koning HD; Bodar EJ; Simon A; van der Hilst JC; Netea MG; van der Meer JW
Ann Rheum Dis; 2006 Apr; 65(4):542-4. PubMed ID: 16096327
[TBL] [Abstract][Full Text] [Related]
16. Sustained efficacy of the monoclonal anti-interleukin-1 beta antibody canakinumab in a 9-month trial in Schnitzler's syndrome.
de Koning HD; Schalkwijk J; van der Ven-Jongekrijg J; Stoffels M; van der Meer JW; Simon A
Ann Rheum Dis; 2013 Oct; 72(10):1634-8. PubMed ID: 23087179
[TBL] [Abstract][Full Text] [Related]
17. Schnitzler's syndrome: A female elderly case presenting intractable non-pruritic febrile urticarial rush.
Kimura N; Takeshita H; Kai T; Inoue Y; Furue M
Asian Pac J Allergy Immunol; 2020 Mar; 38(1):64-66. PubMed ID: 30525744
[TBL] [Abstract][Full Text] [Related]
18. Long-term effectiveness and safety of interleukin-1 receptor antagonist (anakinra) in Schnitzler's syndrome: a French multicenter study.
Néel A; Henry B; Barbarot S; Masseau A; Perrin F; Bernier C; Kyndt X; Puechal X; Weiller PJ; Decaux O; Ninet J; Hot A; Aouba A; Astudillo L; Berthelot JM; Bonnet F; Brisseau JM; Cador B; Closs-Prophette F; Dejoie T; de Korwin JD; Dhote R; Fior R; Grosbois B; Hachulla E; Hatron PY; Jardel H; Launay D; Lorleac'h A; Pottier P; Moulis G; Serratrice J; Smail A; Hamidou M
Autoimmun Rev; 2014 Oct; 13(10):1035-41. PubMed ID: 25220180
[TBL] [Abstract][Full Text] [Related]
19. Increasing the Interval of Canakinumab Administration Effectively Supports the Remission of Schnitzler's Syndrome.
Gorodetskiy VR; Salugina SO; Fedorov ES
Case Rep Rheumatol; 2018; 2018():5416907. PubMed ID: 29850358
[TBL] [Abstract][Full Text] [Related]
20. Refractory urticaria and the importance of diagnosing Schnitzler's syndrome.
Nham T; Saleh C; Chu D; Vakaljan SL; Ohayon JA; Siegal DM
BMJ Case Rep; 2019 Apr; 12(4):. PubMed ID: 31036740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
